Kosuke Kusamori1, Makiya Nishikawa2,3,4, Narumi Mizuno1, Tomoko Nishikawa1, Akira Masuzawa1, Yutaro Tanaka1, Yuya Mizukami1, Kazunori Shimizu5,6, Satoshi Konishi5,6,7, Yuki Takahashi1,8, Yoshinobu Takakura1,5. 1. Department of Biopharmaceutics and Drug Metabolism Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan. 2. Department of Biopharmaceutics and Drug Metabolism Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan. makiya@pharm.kyoto-u.ac.jp. 3. Institute for Innovative NanoBio Drug Discovery and Development Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan. makiya@pharm.kyoto-u.ac.jp. 4. Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan. makiya@pharm.kyoto-u.ac.jp. 5. Institute for Innovative NanoBio Drug Discovery and Development Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan. 6. Ritsumeikan-Global Innovation Research Organization, Ritsumeikan University, Kusatsu, Shiga, 525-8577, Japan. 7. Department of Mechanical Engineering, Ritsumeikan University, Kusatsu, Shiga, 525-8577, Japan. 8. Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan.
Abstract
PURPOSE: We previously have shown that multicellular spheroids containing insulin-secreting cells are an effective therapy for diabetic mice. Here we attempted to increase insulin secretion by incorporating other cell types into spheroids. MATERIALS AND METHODS: Multicellular spheroids of mouse MIN6 pancreatic β cells were formed in microwells alone and with aortic vascular endothelial MAEC cells or embryo fibroblast NIH3T3 cells. mRNA expression of insulin genes and insulin secretion of MIN6 cells in each spheroid were measured by real-time PCR and an insulin ELIZA kit. Moreover, collagen IV expression in each spheroid was analyzed by western blot. RESULTS: In all cases, uniformly sized (about 300 μm) multicellular spheroids were obtained. MAEC or NIH3T3 cell incorporation into MIN6 spheroids significantly increased mRNA expression of insulin genes and insulin secretion. In addition, collagen IV expression, which was reported to enhance insulin secretion from pancreatic β cells, also increased in their spheroids. CONCLUSIONS: The formation of mixed multicellular spheroids containing collagen IV-expressing cells can improve the insulin secretion from insulin-secreting MIN6 cells, and mixed multicellular spheroids can be a potent therapeutic option for patients with type I diabetes mellitus.
PURPOSE: We previously have shown that multicellular spheroids containing insulin-secreting cells are an effective therapy for diabeticmice. Here we attempted to increase insulin secretion by incorporating other cell types into spheroids. MATERIALS AND METHODS: Multicellular spheroids of mouse MIN6 pancreatic β cells were formed in microwells alone and with aortic vascular endothelial MAEC cells or embryo fibroblast NIH3T3 cells. mRNA expression of insulin genes and insulin secretion of MIN6 cells in each spheroid were measured by real-time PCR and an insulin ELIZA kit. Moreover, collagen IV expression in each spheroid was analyzed by western blot. RESULTS: In all cases, uniformly sized (about 300 μm) multicellular spheroids were obtained. MAEC or NIH3T3 cell incorporation into MIN6 spheroids significantly increased mRNA expression of insulin genes and insulin secretion. In addition, collagen IV expression, which was reported to enhance insulin secretion from pancreatic β cells, also increased in their spheroids. CONCLUSIONS: The formation of mixed multicellular spheroids containing collagen IV-expressing cells can improve the insulin secretion from insulin-secreting MIN6 cells, and mixed multicellular spheroids can be a potent therapeutic option for patients with type I diabetes mellitus.
Authors: Meirigeng Qi; Katie Kinzer; Kirstie K Danielson; Joan Martellotto; Barbara Barbaro; Yong Wang; James T Bui; Ron C Gaba; Grace Knuttinen; Raquel Garcia-Roca; Ivo Tzvetanov; Andrew Heitman; Maureen Davis; James J McGarrigle; Enrico Benedetti; Jose Oberholzer Journal: Acta Diabetol Date: 2014-07-18 Impact factor: 4.280
Authors: Max Urbanczyk; Aline Zbinden; Shannon L Layland; Garry Duffy; Katja Schenke-Layland Journal: Tissue Eng Part A Date: 2019-12-20 Impact factor: 3.845